<!DOCTYPE html>
<html lang="en">

<head>
  <title>Ischemic Heart Disease | The Peripheral Brain</title>
  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">

  <script src='https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.2/MathJax.js?config=TeX-MML-AM_CHTML'></script>

  <link rel="stylesheet" href="/peripheral_brain/css/main.css" />
  <link rel="stylesheet" href="/peripheral_brain/css/mobile.css" />

  <link href="https://fonts.googleapis.com/css?family=Open+Sans" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Slab" rel="stylesheet">
  <link href="https://fonts.googleapis.com/css?family=Roboto+Mono" rel="stylesheet">


  <link rel="apple-touch-icon" sizes="57x57" href="/peripheral_brain/favicons/apple-icon-57x57.png">
  <link rel="apple-touch-icon" sizes="60x60" href="/peripheral_brain/favicons/apple-icon-60x60.png">
  <link rel="apple-touch-icon" sizes="72x72" href="/peripheral_brain/favicons/apple-icon-72x72.png">
  <link rel="apple-touch-icon" sizes="76x76" href="/peripheral_brain/favicons/apple-icon-76x76.png">
  <link rel="apple-touch-icon" sizes="114x114" href="/peripheral_brain/favicons/apple-icon-114x114.png">
  <link rel="apple-touch-icon" sizes="120x120" href="/peripheral_brain/favicons/apple-icon-120x120.png">
  <link rel="apple-touch-icon" sizes="144x144" href="/peripheral_brain/favicons/apple-icon-144x144.png">
  <link rel="apple-touch-icon" sizes="152x152" href="/peripheral_brain/favicons/apple-icon-152x152.png">
  <link rel="apple-touch-icon" sizes="180x180" href="/peripheral_brain/favicons/apple-icon-180x180.png">
  <link rel="icon" type="image/png" sizes="192x192"  href="/peripheral_brain/favicons/android-icon-192x192.png">
  <link rel="icon" type="image/png" sizes="32x32" href="/peripheral_brain/favicons/favicon-32x32.png">
  <link rel="icon" type="image/png" sizes="96x96" href="/peripheral_brain/favicons/favicon-96x96.png">
  <link rel="icon" type="image/png" sizes="16x16" href="/peripheral_brain/favicons/favicon-16x16.png">
  <link rel="manifest" href="/peripheral_brain/favicons/manifest.json">
  <meta name="msapplication-TileColor" content="#748cab">
  <meta name="msapplication-TileImage" content="/peripheral_brain/favicons/ms-icon-144x144.png">
  <meta name="theme-color" content="#748cab">
</head>


<body class="body">
<header>
  <nav>
    <!-- <a href="/peripheral_brain/home.html"><img src="/peripheral_brain/images/logo_1000x1000.png" alt="Logo"> -->
      <ul class="nav-links">
        <li><a href="/peripheral_brain/home.html">Home</a></li>
        <li><a href="/peripheral_brain/disease_list.html">Diseases and Drugs</a></li>
        <li><a href="/peripheral_brain/lab_values">Lab Values</a></li>
        <li><a href="/peripheral_brain/formulas">Formulas</a></li>
        <li><a href="/peripheral_brain/calculators.html">Calculators</a></li>
      </ul>
  </nav>
</header>


<div class="contents">
<h1 class="title">Ischemic Heart Disease</h1>
<div class="toc">

  <h4>Table of Contents</h4>
  <ul>
  <li><a href="#cardiac-anatomy">Cardiac Anatomy</a>
    <ul>
      <li><a href="#athlerosclerosis">Athlerosclerosis</a></li>
    </ul>
  </li>
  <li><a href="#general-angina">General Angina</a>
    <ul>
      <li><a href="#pathophysiology">Pathophysiology</a></li>
      <li><a href="#oxygen-supply-and-demand">Oxygen Supply and Demand</a></li>
      <li><a href="#risk-factors">Risk Factors</a></li>
    </ul>
  </li>
  <li><a href="#stable-angina">Stable Angina</a>
    <ul>
      <li><a href="#pathophysiology-1">Pathophysiology</a></li>
      <li><a href="#clinical-presentation-and-dx">Clinical Presentation and Dx</a>
        <ul>
          <li><a href="#dx">Dx</a></li>
          <li><a href="#pqrst">PQRST</a></li>
          <li><a href="#common-precipitating-factors">Common Precipitating Factors</a></li>
          <li><a href="#ekg-findings">EKG Findings</a></li>
        </ul>
      </li>
      <li><a href="#treatment">Treatment</a>
        <ul>
          <li><a href="#common-drug-classes-for-treatment">Common Drug Classes for Treatment</a></li>
          <li><a href="#algorithm">Algorithm</a></li>
        </ul>
      </li>
    </ul>
  </li>
  <li><a href="#prinzmetals-variable-angina">Prinzmetal’s (Variable) Angina</a>
    <ul>
      <li><a href="#pathophysiology-2">Pathophysiology</a></li>
      <li><a href="#treatment-1">Treatment</a>
        <ul>
          <li><a href="#common-drug-classes-for-treatment-1">Common Drug Classes for Treatment</a></li>
        </ul>
      </li>
    </ul>
  </li>
  <li><a href="#unstable-angina">Unstable Angina</a>
    <ul>
      <li><a href="#pathophysiology-3">Pathophysiology</a></li>
      <li><a href="#treatment-2">Treatment</a>
        <ul>
          <li><a href="#common-drug-classes-for-treatment-2">Common Drug Classes for Treatment</a></li>
        </ul>
      </li>
    </ul>
  </li>
  <li><a href="#cardiac-syndrome-x">Cardiac Syndrome X</a></li>
  <li><a href="#silent-myocardial-ischemia">Silent Myocardial Ischemia</a></li>
</ul>


</div>

<h1 id="cardiac-anatomy">Cardiac Anatomy</h1>

<p><img src="../images/coronaryCirculation.gif" alt="Coronary Arteries" /></p>

<h2 id="athlerosclerosis">Athlerosclerosis</h2>

<p>Athlerosclerosis occluds arteries, and when a large amount of a coronary artery is obstructed, angina can occur. The process of athlerosclerotic development is as follows:</p>

<ol>
  <li>LDL accumulation and oxidation in the wall of a vessel</li>
  <li>Macrophage infiltration and uptake of the LDL deposit</li>
  <li>Formation of foam cells</li>
  <li>Smooth Muscle proliferation and Cap formation</li>
  <li>Cap rupture</li>
  <li>Thrombosis</li>
</ol>

<h1 id="general-angina">General Angina</h1>

<h2 id="pathophysiology">Pathophysiology</h2>

<p>Oxygen demand to cardiac tissue exceeds the ability of coronary circulation to supply oxygen to the cardiac myocytes, leading to ischemia and chest pain</p>

<h2 id="oxygen-supply-and-demand">Oxygen Supply and Demand</h2>

<p><strong>Preload:</strong> Decreased preload is caused by veinous vasodilation, resulting in decreased oxygen consumption and increased myocardial perfusion</p>

<p><strong>Afterload:</strong> Decreased afterload is caused by arterial vasodilation, leading to decreased oxygen consumption</p>

<p><strong>Heart Rate:</strong> Decreased HR leads to decreased oxygen consumption and increased coronary perfusion</p>

<h2 id="risk-factors">Risk Factors</h2>

<ul>
  <li>Age: ≥ 55 for men or ≥ 65 for women</li>
  <li>Smoking</li>
  <li>DM</li>
  <li>HTN</li>
  <li>Kidney Disease</li>
  <li>Obesity</li>
  <li>Sedentary Lifestyle</li>
</ul>

<h1 id="stable-angina">Stable Angina</h1>

<h2 id="pathophysiology-1">Pathophysiology</h2>

<p>Stable angina is a demand ischemia caused by a temporary increase in O<sub>2</sub> demand by cardiac myocytes in the prescense of a diminished O<sub>2</sub> supply, most commonly the result of severe ASCVD leading to significant decreases in blood flow (&gt;70%) through the coronary arteries <strong>without</strong> myocardial necrosis. Stable angina can be of either a fixed threshold, a variable threshold, or both. Stable angina should have stable characteristics for at least 2 months.</p>

<h2 id="clinical-presentation-and-dx">Clinical Presentation and Dx</h2>

<h3 id="dx">Dx</h3>

<ul>
  <li>Look for risk factors</li>
  <li>ST-Depression <strong>During</strong> Angina</li>
  <li>Stress Test</li>
  <li>Cardiac Catheterization</li>
  <li>Electron Beam CT (AHA does not reccomend because results will not change recommendation)</li>
</ul>

<h3 id="pqrst">PQRST</h3>

<ul>
  <li>Precipitating Factors: Exertion etc</li>
  <li>Palliative Measures: Rest and/or SL NTG</li>
  <li>Quality of Pain: Squeezing, heaviness, tightening, etc</li>
  <li>Region and Radiation: Substernal, ocassionally radiating to left arm</li>
  <li>Severity of Pain: Generally &gt;5</li>
  <li>Timing: Typically 5-10min, must be &lt; 20</li>
</ul>

<h3 id="common-precipitating-factors">Common Precipitating Factors</h3>

<ul>
  <li>Cold Air (leads to increased HR)</li>
  <li>Large Meals</li>
  <li>Exertion</li>
  <li>Smoking</li>
</ul>

<h3 id="ekg-findings">EKG Findings</h3>

<p>ST-Depression <strong>only during episodes of angina</strong>, EKG is otherwise unremarkable</p>

<h2 id="treatment">Treatment</h2>

<h3 id="common-drug-classes-for-treatment">Common Drug Classes for Treatment</h3>

<ul>
  <li>Organic Nitrates: Dilation of Venous Blood Vessels to Reduce Preload
    <ul>
      <li>Glyceryl Trinitrate for acute attacks</li>
      <li>IS(M/D)N for prophylaxis</li>
    </ul>
  </li>
  <li>DHP CCBs: Arterial Vasodilation to Decrease Afterload</li>
  <li>Non-DHP CCBs: Negative Inotropy and Chronotropy to Decrease Oxygen Consumption</li>
  <li>β-Blockers: Negative Inotropy and Chronotropy to Decrease Oxygen Consumption</li>
  <li>Ivabradine: Negative Chronotropy via HCN Inhibition to Decrease Oxygen Consumption</li>
  <li>Ranolazine: Inhibits late-Na current to inhibit reverse calcium transport during ischemic attacks</li>
  <li>Statins: Decrease Athlerosclerosis</li>
  <li>Paclitaxel: Binds and Stabilizes Microtubules to prevent mitosis in stent placement</li>
  <li>Sirolimus: Binds FKBP12, inhibiting mTOR and arresting the cell cycle at the G<sub>1</sub>-S transition</li>
</ul>

<h3 id="algorithm">Algorithm</h3>

<p><img src="../images/sidhTreatment.svg" alt="SIHD Sx Managment" /></p>

<h1 id="prinzmetals-variable-angina">Prinzmetal’s (Variable) Angina</h1>

<h2 id="pathophysiology-2">Pathophysiology</h2>

<p>Prinzmetal’s angina is a supply ischemia resulting from spontaneous vasospasm in the coronary vessels, typically the result of athlerosclerotic insult to the endothelium, leading to a short-lived ischemia. Prinzmetal’s angina typically presents at night when parasympathetic tone is higher.</p>

<h2 id="treatment-1">Treatment</h2>

<h3 id="common-drug-classes-for-treatment-1">Common Drug Classes for Treatment</h3>

<ul>
  <li>Organic Nitrates: Dilation of Venous Blood Vessels to Reduce Preload
    <ul>
      <li>Glyceryl Trinitrate for acute attacks</li>
      <li>IS(M/D)N for prophylaxis</li>
    </ul>
  </li>
  <li>DHP CCBs: Arterial Vasodilation to Decrease Afterload</li>
  <li>Non-DHP CCBs: Negative Inotropy and Chronotropy to Decrease Oxygen Consumption</li>
  <li>β-Blockers: Negative Inotropy and Chronotropy to Decrease Oxygen Consumption</li>
  <li>Ivabradine: Negative Chronotropy via HCN Inhibition to Decrease Oxygen Consumption</li>
  <li>Ranolazine: Inhibits late-Na current to inhibit reverse calcium transport during ischemic attacks</li>
  <li>Statins: Decrease Athlerosclerosis</li>
</ul>

<h1 id="unstable-angina">Unstable Angina</h1>

<h2 id="pathophysiology-3">Pathophysiology</h2>

<p>Unstable angina is supply ischemia characterized by a rapid worsening of athlerosclerosis of a coronary vessel in which the cap of the deposit ruptures, leading to thrombus formation. Unstable angina typically onsets suddenly and typically warns of an impending MI.</p>

<h2 id="treatment-2">Treatment</h2>

<h3 id="common-drug-classes-for-treatment-2">Common Drug Classes for Treatment</h3>

<ul>
  <li>ASA: Decrease Platelt Aggregation / Inhibit Thrombus Formation</li>
  <li>P2Y12 Inhibitors (Clopidogrel, Prasgurel, Ticagrelor): Inhibit Platelt Activation / Inhibit Thrombus Formation</li>
  <li>Heparin: Inhibition of Thrombin via AT-III to inhibit coagulation cascade</li>
</ul>

<h1 id="cardiac-syndrome-x">Cardiac Syndrome X</h1>

<h1 id="silent-myocardial-ischemia">Silent Myocardial Ischemia</h1>



</div>

<div class="credits">
  <p>Author: Corbin Cox <br>
  Created: 2018-1-29 <br>
  Last Updated: 2018-1-29</p>
</div>

<footer class="footer menus">
  <nav>
    <ul class="footer-links">
      <li><a href="/peripheral_brain/news_archive.html">News Archive</a></li>
      <li><a href="/peripheral_brain/index.html">Disclaimer</a></li>
    </ul>
    <!-- <a href="/peripheral_brain/home.html"><img src="/peripheral_brain/images/logo_1000x1000.png" alt="Logo"> -->
  </nav>
</footer>


</body>
</html>
